Boehringer Ingelheim Venture Fund returned to reinvest in the regenerative therapy developer after backing its series A round two years ago.

The regenerative therapy developer is based on research at University of Torino and has raised capital from returning backer V-Bio Ventures.

Lenovo’s corporate venturing arm led a pre-series B round for Style3D, a provider of 3D modelling software for the fashion industry.

HubSpot, Okta and Siemens’ Next47 unit were among the investors in the data compliance software provider’s latest round.

Sapphire Ventures led a round for the app management technology provider that included Dell Technologies Capital, Intel Capital, NTT Venture Capital and Samsung Next.

Tencent and existing investor Nan Fung Life Sciences have helped the ophthalmology drug developer complete its series B round.

Cybrexa has secured $25m to progress a cancer treatment based on research at Yale University and University of Rhode Island.

Dell Technologies Capital returned for a round that took the cancer diagnostics technology developer's overall funding to $52m.

Kraft Group and IHeartMedia Ventures were among the investors that helped the licensed music provider double its total funding to $22m.

Koch Disruptive Technologies has provided $110m for the drug discovery technology startup's series B round following a $190m first close in January.